ClinicalTrials.Veeva

Menu

Effects of Myofascial Release in Cerebral Palsy Children

R

Riphah International University

Status

Completed

Conditions

Cerebral Palsy

Treatments

Other: myofascial release
Other: myofascial release and quick icing

Study type

Interventional

Funder types

Other

Identifiers

NCT06198140
REC/RCR&AHS/23/0750

Details and patient eligibility

About

Cerebral palsy (CP) is a common disorder which leads to physical disability in children throughout life and begins in early childhood. In cerebral palsy spasticity is considered as a primary factor leads to much impairment which is inversely related to functional development that means greater the spasticity lowers the level of function. There are many ways to treat spasticity which involve stretching, strengthening, postural education, neuromuscular electrical stimulation, cryotherapy and myofascial release technique.

Full description

This study will be a randomized controlled trial. Study will be approved by ethical committee. After that informed consent will be taken and patients will be included in the study on the basis of inclusion criteria. Non probability convenience sampling technique will be used and study will be conducted on 28 patients with spastic hemiplegic cerebral palsy, 6 to 12 years of age. Patient will be randomly categorize into two groups by using flip coin. Experimental group will receive myofascial release on ankle planterflexors and quick icing treatment protocol on ankle dorsiflexors. Control group will receive only myofascial release treatment protocol on ankle planterflexors. Pre and Post intervention assessment will be made for both groups. Tone of planterflexors will be assessed by Modified Ashworth Scale, ankle passive range of motion will be assessed by goniometer and static balance will be assessed by Romberg test(open eyes).

Enrollment

28 patients

Sex

All

Ages

6 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects with hemiplegic cerebral palsy
  • Both genders
  • Age between 6 to 12 years
  • GMFCS Level I and II
  • Modified Ashworth scale (grade1 - grade 3

Exclusion criteria

  • Hypersensitive to cold
  • Underwent any corrective surgery
  • Specific perceptual and cognitive impairments
  • Subjects who has received Botulinium toxin injection in the past 6 months

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

28 participants in 2 patient groups

Myofascial Release and Quick icing
Experimental group
Description:
Experimental group will receive myofascial release \& quick icing.
Treatment:
Other: myofascial release and quick icing
Myofascial Release
Active Comparator group
Description:
In control group the individuals will receive only myofascial release on ankle planterflexors.
Treatment:
Other: myofascial release

Trial contacts and locations

1

Loading...

Central trial contact

Imran amjad, PhD; Muhammad Asif Javed, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems